[Primary prevention of gastroduodenal ulcer: what is the evidence?].
Primary prevention of gastroduodenal ulcer and its major complication, gastrointestinal bleeding, has been studied mainly in the intensive care environment. Proton pump inhibitors (PPIs), H2-receptor antagonists and sucralfate have proved effective. By extension, PPIs are inappropriately prescribed in a variety of clinical situations. In contrast, they are probably underused in patients chronically treated by nonsteroidal anti-inflammatory drugs. This article reviews the situations in which an increased ulcer risk justifies primary prevention. Validated prophylactic options are also addressed.
Pfaender
S
S
Service de médecine interne générale HUG, 1211 Genève.
Perrier
A
A
Nendaz
M
M
D000369:Aged, 80 and over; D000897:Anti-Ulcer Agents / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010437:Peptic Ulcer / Q000517:prevention & control*; D011322:Primary Prevention; D012307:Risk Factors
D000897:Anti-Ulcer Agents